
Prime Peptides (Prime Vitality, Inc.) received an FDA warning letter on December 10, 2024 — part of a four-vendor enforcement wave that also targeted Swiss Chems, Xcel Peptides, and Summit Research. The FDA cited the company for selling semaglutide, tirzepatide, and retatrutide as unapproved drugs with evidence of intended human use, in violation of FDCA sections 505(a) and 301(d). The company was given 15 days to respond with corrective procedures. On the chemistry side, a BPC-157 batch (lot 5132025BP, July 2025) tested at 82.39% purity — a confirmed quality failure on the most commonly purchased peptide they carry. Other tested products run clean. No physical address, no ownership disclosure. The FDA action, the BPC-157 failure, and the missing identity transparency make this a vendor we cannot recommend.
| Vendor Score | 38/100 (High Risk) |
| Latest Tested Batch(Jul 2025) | GHK-Cu — 99.8% Purity |
| Batch Grade | A |
| Tested By | Lab E |
Several Reddit users actively recommend Prime Peptides for their ordering process and peptide calculators, highlighting ease of use and affordability. Users have shared positive experiences with their products, particularly semaglutide and Retatrutide, indicating satisfaction with their purchases.
Prime Peptides receives a mix of positive feedback for its peptide calculator and user experience, with several users recommending it for ease of use. However, there are also warnings about potential scams associated with different Prime Peptides vendors, particularly in Australia, indicating a lack of consistency in user experiences.
Multiple Reddit users have shared positive experiences with Prime Peptides, highlighting their excellent ordering process, effective peptide calculator, and good customer service. Many recommend the vendor for its reliable products and user-friendly features.
| Peptide | Price | Status |
|---|---|---|
| AOD 9604 | $50.00 | In Stock |
| BPC-157 | $60.00 | In Stock |
| CJC & Ipa | $75.00 | In Stock |
| GHK-Cu | $65.00 | In Stock |
| GLP-2 | $115.00 | In Stock |
| Ipamorelin | $55.00 | In Stock |
| Melanotan I | $45.00 | In Stock |
| Melanotan II | $40.00 | In Stock |
| MOTS-c | $55.00 | In Stock |
| NAD+ | $125.00 | In Stock |
| Retatrutide | $120.00 | In Stock |
| Selank | Semax | $90.00 | In Stock |
| Semaglutide | $80.00 | In Stock |
| Semax | $50.00 | In Stock |
| Sermorelin | $65.00 | In Stock |
| TB-500 (TB4) | $75.00 | In Stock |
| Tesamorelin | $60.00 | In Stock |